Fred Khosravi , MS
Director
Access Closure, Inc.
Mountain View, CA
Fred is the Managing Director of Incept LLC a Health Sciences and technology development company. Incept has to-date, started five companies: AccessClosure, Inc., Embolic Protection, Inc., Confluent Surgical, Inc., MarketRx, Inc., and SquareOne, Inc., Fred also serves on the Boards of: Sadra Medical, Inc., and Kerberos Proximal Solutions, Inc., Fred was also Founder, Chairman and Chief Technical Officer of EndoTex Interventional Systems, Inc., a company in the carotid stent market. Prior to his entrepreneurial career, Fred was Engineering Manager in the initial management team at Focal, Inc. (acquired by Genzyme Biosurg Nasdaq:GZBX), responsible for its cardiovascular products. He was also the Business Unit Manager of the Stent Business at Guidant/ACS where he led the initial design and development team of the highly successful Multilink stent.
Prior to ACS (from 1986 through 1989) he held several management positions with Alcon Surgical Corp., developing pioneering small-incision intraocular lenses. Fred is either the author or co-author on over 40 issued or filed patent applications, involving unique and novel medical devices. Fred has a B.S. degree in Mechanical Engineering, and graduated summa cum laude obtaining a Master of Science degree in Mechanical Engineering from Tennessee.

Contact Information
645 Clyde Ave
Mountain View, CA
fkhosravi@embolicprotection.com
Category
Research Interests
Links

